This inventor holds 1 USPTO granted patent. Top assignee: Captivate Pharmaceuticals, LLC. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Tulin Morcol: Innovator in Therapeutic Calcium Phosphate Particles
Introduction
Tulin Morcol is a notable inventor based in Elkins Park, PA (US). He has made significant contributions to the field of biomedical materials, particularly through his innovative work on calcium phosphate particles. His research focuses on the development of novel materials that can enhance vaccine efficacy and deliver biologically active substances.
Latest Patents
Tulin Morcol holds a patent for "Therapeutic calcium phosphate particles and methods of manufacture and use." This patent describes the creation of calcium phosphate core particles that can serve multiple purposes, including as vaccine adjuvants and carriers for biologically active materials. The core particles are designed to have a diameter ranging from about 300 nm to about 4000 nm, with a preference for sizes between 300 nm and 2000 nm. These particles are characterized by their substantially spherical shape and smooth surface, which can be modified with surface agents or biologically active materials.
Career Highlights
Morcol is associated with Captivate Pharmaceuticals, LLC, where he applies his expertise in the development of innovative therapeutic solutions. His work has the potential to impact various medical applications, particularly in vaccine development and drug delivery systems.
Collaborations
Tulin Morcol collaborates with esteemed colleagues, including Steve J D Bell and Qing He, who contribute to the advancement of his research initiatives. Their combined efforts aim to push the boundaries of current biomedical technologies.
Conclusion
Tulin Morcol's contributions to the field of therapeutic calcium phosphate particles exemplify the innovative spirit of modern inventors. His work not only enhances our understanding of material science but also holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile